- Patent Title: Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors
-
Application No.: US15774332Application Date: 2016-11-24
-
Publication No.: US11136310B2Publication Date: 2021-10-05
- Inventor: Rebecca Louise Charlton , Teresa De Haro Garcia , Martin Alexander Lowe , Malcolm Maccoss , Trevor Morgan , Richard David Taylor , Zhaoning Zhu
- Applicant: UCB Biopharma SPRL
- Applicant Address: BE Brussels
- Assignee: UCB Biopharma SPRL
- Current Assignee: UCB Biopharma SPRL
- Current Assignee Address: BE Brussels
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: GB1520808 20151125,GB1612944 20160726
- International Application: PCT/EP2016/078664 WO 20161124
- International Announcement: WO2017/089453 WO 20170601
- Main IPC: C07D403/10
- IPC: C07D403/10 ; C07D417/10 ; C07D471/04

Abstract:
A series of 2-imino-6-methyltetrahydropyrimidin-4(1H)-one derivatives, substituted in the 6-position by a phenyl moiety which in turn is meta-substituted by an optionally substituted unsaturated fused bicyclic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.
Public/Granted literature
- US20200283416A1 IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS Public/Granted day:2020-09-10
Information query